Trading Signals: ANPC Stock Price Prediction and Forecast (Thu. Jan. 30, 2020 - Fri. May. 13, 2022)(AnPac Bio-Medical Science Co Ltd - ADR)
| ANPC latest price $0.3768 (-6.27%) ($0.3768 - $0.3768) on Thu. Apr. 21, 2022. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 10.63% (three month average) | RSI | 39 | Latest Price | $0.3768(-6.27%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | ANPC declines -4.6% a day on average for past five trading days. | Weekly Trend | ANPC declines -3.3% a week on average for past two weeks. | Market Behavior | Broad based sell-off for large cap. Broad based sell-off for small cap. | Correlated ETFs | Broad market will support ANPC advance at 0% a week (0% probability) PAVE(78%) EWI(76%) XLK(74%) QQQ(68%) BOTZ(65%) | Factors Impacting ANPC price | ANPC will decline at least -5.315% in a week (0% probabilities). SHY(-27%) TIP(-25%) BNDX(-23%) BND(-20%) VCSH(-14%) | | | | | Relative Volatility | | | | Market Trend Strength | -5.315% (StdDev 10.63%) | Hourly BBV | 0 () | Intraday Trend | 0% | | | |
|
Resistance Level | $0.44 | 5 Day Moving Average | $0.42(-10.29%) | 10 Day Moving Average | $0.44(-14.36%) | 20 Day Moving Average | $0.44(-14.36%) | To recent high | -63.8% | To recent low | 0% | Market Cap | $3m | | | | Anpac Bio-Medical Science Co. Ltd., is a biotechnology company. It engages in marketing and selling multi-cancer screening and detection test that uses patented cancer differentiation analysis, or CDA, technology and proprietary cancer-detection device or CDA device. The company was founded by Chris Chang Yu and He Yu in 2010 and is headquartered in Lishui, China. |